Columbia, MD, United States of America

Kimberly Kentner


Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Kimberly Kentner: Pioneering Bioactive Gel Manufacturing

Introduction

Kimberly Kentner, an inventive force based in Columbia, MD, holds an impressive portfolio of five patents. Her contributions to the field of tissue engineering and regenerative medicine have garnered attention and recognition, particularly for her innovative methods of creating bioactive gels from extracellular matrix (ECM) material.

Latest Patents

Among her latest patents is a method for manufacturing bioactive gels from ECM material. This groundbreaking invention emphasizes producing gels that retain bioactivity, serving as scaffolds for both preclinical and clinical tissue engineering. The significance of her work lies in the novel recognition that these bioactive gels can be synthesized by digesting specific ECM material in an alkaline environment and neutralizing it to develop suitable bioactive gels.

Career Highlights

Kimberly Kentner’s career has been marked by her commitment to enhancing biomedical solutions through innovative inventions. Working at Acell, Inc., she has made significant strides in medical science, focusing on advancements that promise to revolutionize tissue reconstruction methodologies.

Collaborations

Throughout her professional journey, Kentner has collaborated with notable colleagues, including Katherine A. Stuart and Abram D. Janis. These collaborations highlight the importance of teamwork in driving innovation forward in their respective fields, contributing to the successful development of transformative health solutions.

Conclusion

In conclusion, Kimberly Kentner stands out as a remarkable inventor whose work in manufacturing bioactive gels is set to influence the landscape of tissue engineering significantly. Her innovative methodologies not only promise to advance regenerative medicine but also reflect her commitment to improving patient outcomes through cutting-edge research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…